Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 8/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20849055 | 0.95 | AR (0.36) | ARCYP11B1CYP11B2SMN1; SMN2 | |
| SCHEMBL20849054 | 0.95 | AR (0.43) | ARCYP11B1CYP11B2PGRRXRA | |
| SCHEMBL20848982 | 0.93 | AR (0.36) | ARCYP11B1CYP11B2PGRRXRA | |
| SCHEMBL20849337 | 0.93 | CYP11B1 (0.36) | ARCYP11B1CYP11B2RXRA | |
| SCHEMBL20848588 | 0.93 | AR (0.35) | ARCYP11B1CYP11B2 | |
| SCHEMBL20848689 | 0.92 | AR (0.46) | ARCYP11B1CYP11B2PGR | |
| SCHEMBL20849353 | 0.91 | CYP11B1 (0.35) | ARCYP11B1CYP11B2RXRATSHR | |
| SCHEMBL20848687 | 0.91 | AR (0.39) | ARCYP11B1CYP11B2 | |
| SCHEMBL20848987 | 0.91 | AR (0.34) | ARCYP11B1CYP11B2PGRRXRA | |
| SCHEMBL20849050 | 0.90 | ICMT (0.35) | ARCYP11B1CYP11B2PGRTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-13 | — | — | US | disclosed |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | OCIAD2, OCIAD1, POU2F1 | AR 3706/4885CYP11B1 2072/4885CYP11B2 2189/4885 |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD2, OCIAD1, POU2F1 | AR 3706/4885CYP11B1 2072/4885CYP11B2 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.